Brian Levy is listed as a director on 3 SEC Form D filings by 2 issuers between Jun 2013 and Oct 2017: OCULAR THERAPEUTIX, INC (Bedford, MA — biotechnology — 2013; $37.5M reported sold to 29 investors) and SILK TECHNOLOGIES, LTD. (Plymouth, MN — biotechnology — 2017; $5M reported sold to 1 investors).
What this means 2 separate companies raised money with this person listed as director, over about 4 years. Across those companies the filings report $42.5M sold in total.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — 6 bankruptcy cases matching the name listed in Key records below.
What this means 6 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 3 public filings for Brian Levy and found 5 differences: No amendment in the last 12 months on an offering that may still be open; Same name, different state: "Brian Levy" (NY) is a separate record; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.